This study has some limitations, including the lack of data on viral load, comorbidities, and vaccination status; the potential underreporting of mild or asymptomatic cases; the restriction to male participants, due to the methodology used to identify complete G6PD deficiency; and the fact that G6PD testing was not performed during the pandemic. This evidence concerns the gene G6PD and G6PD deficiency.